-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6

Benzinga·08/07/2026 21:08:31
Listen to the news
TD Cowen analyst Marc Frahm maintains Puma Biotechnology (NASDAQ:PBYI) with a Hold and raises the price target from $5 to $6.